UMIN ID: UMIN000000647
Registered date:22/03/2007
To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalization
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | ARMD,BRVO,CRVO,DR,CNV |
| Date of first enrollment | 2007/04/01 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Intravitreal injection |
Outcome(s)
| Primary Outcome | To acess side-effect and examin visual acuity,thickness of retina and retinal angiography |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Cr>3.0mg/dL anstable angina malignant arrhythmia HT:140/80mmHg> |
Related Information
| Primary Sponsor | Department of Ophtalmology of Keio University Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Ophtalmology of Keio University Hospital |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Sinanomachi 35,Sinjukuku Japan |
| Telephone | 03-3353-1211 |
| Affiliation | Department of Ophthalmology Department of Ophthalmology |
| scientific contact | |
| Name | Makoto Inoue |
| Address | Sinanomachi35,Sinjukuku Japan |
| Telephone | 03-3353-1211 |
| Affiliation | Keio University Hospital Ophtalmology |